Cecilia Icoresi Mazzeo

Cecilia Icoresi Mazzeo

Auto-generated profile, based on publicly available information

Cecilia Icoresi Mazzeo

Wellcome Sanger Institute, Cambridge, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2018 in Nature
Verified
Journal Article
Closed access
PDF file
VPVicente Pérez-García
Vicente Pérez-García
EFElena Fineberg
Elena Fineberg
RWRobert Wilson
Robert Wilson
AMAlexander Murray
Alexander Murray
CMCecilia Icoresi Mazzeo
Cecilia Icoresi Mazzeo
MHMyriam Hemberger
Myriam Hemberger

27 February 2017 in Wellcome Open Research
Verified
Journal Article
Open access
PDF file
RWRobert Wilson
Robert Wilson
SGStefan H. Geyer
Stefan H. Geyer
LRLukas Reissig
Lukas Reissig
JRJulia Rose
Julia Rose
DSDorota Szumska
Dorota Szumska
WWWolfgang J. Weninger
Wolfgang J. Weninger
Background: Identifying genes that are essential for mouse embryonic development and survival through term is a powerful and unbiased way to discover possible genetic determinants of human developmental disorders. Characterising the changes in mouse embryos that result from ablation of lethal genes is a necessary first step towards uncovering their role in normal embryonic development and establishing any correlates amongst human congenital abnormalities. Methods: Here we present results gathered to date in the Deciphering the Mechanisms of Developmental Disorders (DMDD) programme, cataloguing the morphological defects identified from comprehensive imaging of 220 homozygous mutant and 114 wild type embryos from 42 lethal and subviable lines, analysed at E14.5. Results: Virtually all mutant embryos show multiple abnormal phenotypes and amongst the 42 lines these affect most organ systems. Within each mutant line, the phenotypes of individual embryos form distinct but overlapping sets. Subcutaneous edema, malformations of the heart or great vessels, abnormalities in forebrain morphology and the musculature of the eyes are all prevalent phenotypes, as is loss or abnormal size of the hypoglossal nerve. Conclusions: Overall, the most striking finding is that no matter how profound the malformation, each phenotype shows highly variable penetrance within a mutant line. These findings have challenging implications for efforts to identify human disease correlates.

26 June 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
JCJohn E. Collins
John E. Collins
RWRichard J. White
Richard J. White
NSNicole Staudt
Nicole Staudt
ISIan M. Sealy
Ian M. Sealy
IPIan Packham
Ian Packham
EBElisabeth M. Busch-Nentwich
Elisabeth M. Busch-Nentwich
The Deciphering the Mechanisms of Developmental Disorders programme has analysed the morphological and molecular phenotypes of embryonic and perinatal lethal mouse mutant lines in order to investigate the causes of embryonic lethality. Here we show that individual whole-embryo RNA-seq of 73 mouse mutant lines (>1000 transcriptomes) identifies transcriptional events underlying embryonic lethality and associates previously uncharacterised genes with specific pathways and tissues. For example, our data suggest that Hmgxb3 is involved in DNA-damage repair and cell-cycle regulation. Further, we separate embryonic delay signatures from mutant line-specific transcriptional changes by developing a baseline mRNA expression catalogue of wild-type mice during early embryogenesis (4–36 somites). Analysis of transcription outside coding sequence identifies deregulation of repetitive elements in Morc2a mutants and a gene involved in gene-specific splicing. Collectively, this work provides a large scale resource to further our understanding of early embryonic developmental disorders.

14 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
EAErick Armingol
Erick Armingol
JAJames Ashcroft
James Ashcroft
MMMagda Mareckova
Magda Mareckova
MPMartin Prete
Martin Prete
VLValentina Lorenzi
Valentina Lorenzi
RVRoser Vento-Tormo
Roser Vento-Tormo
Metabolism supplies energy, building blocks, and signaling molecules vital for cell function and communication, but methods to directly measure it at single-cell and/or spatial resolutions remain technically challenging and inaccessible for most researchers. Single-cell and spatial transcriptomics offer high-throughput data alternatives with a rich ecosystem of computational tools. Here, we present scCellFie, a computational framework to infer metabolic activities from human and mouse transcriptomic data at single-cell and spatial resolution. Applied to ~30 million cell profiles, we generated a comprehensive metabolic atlas across human organs, identifying organ- and cell-type-specific activities. In the endometrium, scCellFie reveals metabolic programs contributing to healthy tissue remodeling during the menstrual cycle, with temporal patterns replicated in data from in vitro cultures. We also uncover disease-associated metabolic alterations in endometriosis and endometrial carcinoma, linked to proinflammatory macrophages, and metabolite-mediated epithelial cell communication, respectively. Ultimately, scCellFie provides a scalable toolbox for extracting interpretable metabolic functionalities from transcriptomic data.

1 January 2019 in Biology Open
Verified
Journal Article
Open access
PDF file
LRLukas Reissig
Lukas Reissig
AHAnna Nele Herdina
Anna Nele Herdina
JRJulia Rose
Julia Rose
BMBarbara Maurer-Gesek
Barbara Maurer-Gesek
JLJenna L. Lane
Jenna L. Lane
WWWolfgang J. Weninger
Wolfgang J. Weninger
The Deciphering the Mechanisms of Developmental Disorders (DMDD) program used a systematic and standardised approach to characterise the phenotype of embryos stemming from mouse lines, which produce embryonically lethal offspring. Our study aims at providing detailed phenotype descriptions of homozygous Col4a2em1(IMPC)Wtsi mutants produced in DMDD and harvested at embryonic day 14.5. This shall provide new information on the role Col4a2 plays in organogenesis and demonstrate the capacity of the DMDD database for identifying models for researching inherited disorders. The DMDD Col4a2em1(IMPC)Wtsi mutants survived organogenesis and thus revealed the full spectrum of organs and tissues, the development of which depends on Col4a2 encoded proteins. They showed defects in the brain, cranial nerves, visual system, lungs, endocrine glands, skeleton, subepithelial tissues and mild to severe cardiovascular malformations. Together, this makes the DMDD Col4a2em1(IMPC)Wtsi line a useful model for identifying the spectrum of defects and for researching the mechanisms underlying autosomal dominant porencephaly 2 (OMIM # 614483), a rare human disease. Thus we demonstrate the general capacity of the DMDD approach and webpage as a valuable source for identifying mouse models for rare diseases.

1 February 2018 in Developmental Biology
Verified
Journal Article
Closed access
LMLuca Massimino
Luca Massimino
LFLisbeth Flores-Garcia
Lisbeth Flores-Garcia
BSBruno Di Stefano
Bruno Di Stefano
GCGaia Colasante
Gaia Colasante
CICecilia Icoresi-Mazzeo
Cecilia Icoresi-Mazzeo
ASAlessandro Sessa
Alessandro Sessa